EUVIMEDEUVIMED entdecken
Crossref

Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants

Abdulaziz F Al Mana iD, Kristen Culp, Abby Keeler, Orlando Perrera, Malini Rajagopalan, Lucien Jacky, Brad Brown, Bharat Thyagarajan iD

Molecular Diagnosis & Therapy · 2024

DOI: 10.1007/s40291-024-00732-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diagnosis & Therapy, 2024. Verfasst von Abdulaziz F Al Mana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Minnesota, 100 Church St SE, Minneapolis, MN, 55455, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, High-Throughput Nucleotide Sequencing, Polymerase Chain Reaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Next-generation sequencing is widely used for comprehensive molecular profiling for many cancers including lung cancer. However, the complex workflows and long turnaround times limit its access and utility. ChromaCode's High Definition PCR Non-Small Cell Lung Cancer Panel (HDPCR™ NSCLC Panel) is a low-cost, rapid turnaround, digital polymerase chain reaction assay that is designed to detect variants in nine NSCLC genes listed in National Comprehensive Cancer Network guidelines. METHODS: This assay uses TaqMan® probe limiting chemistry and proprietary analysis software to enable multi-target detection within a single-color channel. We compared the performance of the HDPCR™ NSCLC Panel against an in-house, laboratory-developed, targeted next-generation sequencing panel used in the Molecular Diagnostics Laboratory at the University of Minnesota Medical Center to detect biomarkers for NSCLC. RESULTS: The overall accuracy of the HDPCR panel was 99.48% (95% confidence interval 99.01-99.76) with a sensitivity of 95.35% (95% confidence interval 88.52-98.72) and a specificity of 99.69% (95% confidence interval 99.29-99.90). The HDPCR wet lab workflow was 4 h, and the time to generate variant calls from raw data using the ChromaCode Cloud was 2 minutes. CONCLUSIONS: We demonstrated that the HDPCR™ NSCLC Panel provides timely, comprehensive, and sensitive mutation detection in NSCLC samples with results in less than 24 h.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHigh-Throughput Nucleotide SequencingPolymerase Chain ReactionHumansBiomarkers, TumorMutationSensitivity and Specificity

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Minnesota, 100 Church St SE, Minneapolis, MN, 55455, USA.
  • ChromaCode, Inc., Carlsbad, CA, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, 100 Church St SE, Minneapolis, MN, 55455, USA. thya0003@umn.edu.

ORCID-Profile: Abdulaziz F Al Mana, Bharat Thyagarajan

Zitieren

APA

Al Mana, A. F., Culp, K., Keeler, A., Perrera, O., Rajagopalan, M., Jacky, L., Brown, B., & Thyagarajan, B. (2024). Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00732-y

Vancouver

Al Mana AF, Culp K, Keeler A, Perrera O, Rajagopalan M, Jacky L, et al. Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants. Molecular Diagnosis & Therapy. 2024. doi:10.1007/s40291-024-00732-y

BibTeX
@article{AlMana2024,
  author = {Al Mana, Abdulaziz F and Culp, Kristen and Keeler, Abby and Perrera, Orlando and Rajagopalan, Malini and Jacky, Lucien and Brown, Brad and Thyagarajan, Bharat},
  title = {Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants},
  journal = {Molecular Diagnosis & Therapy},
  year = {2024},
  doi = {10.1007/s40291-024-00732-y}
}
Kostenlos starten →